По 165 231 вакансии с зарплатой в рублях от 20 000 ₽. Вилка учитывается по середине.
We are Cata-Kor, the leading NAD brand in the US market. In just three years, we've become the leader in the NAD/NMN/Glutathione markets. We're entering the US retail market in October, and we plan to become the leading …
О продукте:Stock Index - это аналитическая платформа для фармацевтического рынка, обеспечивающая клиентов данными о продажах, остатках на полке и потребительских трендах. Мы строим экосистему данных, которая позволяет фа…
We are an international biopharmaceutical company focused on innovation, research and development of prescription medicines, primarily across the following therapeutic areas: oncology, cardiology, nephrology and metaboli…
Tofflon Science and Technology Group Co. Ltd. is a comprehensive pharmaceutical equipment supplier to provide process support, core equipment, integrated system and pharma engineering for the pharma and biotech industry …
Компания Astellas Pharma объявляет конкурс на позицию Бизнес-партнер по доступу препаратов и фармакоэкономике Обязанности: Health Economics & Modeling: development and implementation of HEOR strategies to support global …
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less in…
Purpose Statement: This position is responsible for building/maintaining relationships with internal and external influencers to drive and support Company and product brand reputations. Specific functions performed inclu…
We are Cata-Kor, the leading NAD brand in the US market. In just three years, we've become the leader in the NAD/NMN/Glutathione markets. We're entering the US retail market in October, and we plan to become the leading …
We are Cata-Kor, the leading NAD brand in the US market. In just three years, we've become the leader in the NAD/NMN/Glutathione markets. We're entering the US retail market in October, and we plan to become the leading …